This comprehensive functional genomics study of drug resistance in EGFR-mutated lung cancer revealed that the significant number of resistance genes converged on the Hippo pathway, which consists of a kinase cascade that regulates TEAD-dependent transcription through phosphorylation of the coactivators YAP1 and WWTR1 (TAZ). Here, EGFR is linked to lung carcinoma.